$ARKR
ARK RESTAURANTS CORP Stock $arkr

$arkr Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000077954423000044 Filed on December 21, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023
Revenue	$47.49M	$51.05M	$184.8M
YoY Change	1.28%	-4.07%	0.61%
Cost Of Revenue	$12.07M	$13.24M	$49.62M
YoY Change	-7.41%	-10.17%	-5.61%
Gross Profit	$35.42M	$37.81M	$135.2M
YoY Change	4.63%	-1.74%	3.1%
Gross Profit Margin	74.58%	74.06%	73.15%
Selling, General & Admin	$26.63M	$26.84M	$102.2M
YoY Change	4.33%	3.06%	7.45%
% of Gross Profit	75.19%	70.99%	75.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.092M	$1.059M	$4.225M
YoY Change	3.8%	4.03%	0.76%
% of Gross Profit	3.08%	2.8%	3.13%
Operating Expenses	$33.81M	$34.17M	$130.0M
YoY Change	4.28%	3.38%	7.24%
Operating Profit	$1.603M	$3.637M	-$4.840M
YoY Change	12.57%	-32.91%	-149.07%
Interest Expense	$171.0K	$174.0K	$1.239M
YoY Change	-156.07%	-40.21%	3.94%
% of Operating Profit	10.67%	4.78%
Other Income/Expense, Net	$151.0K	$26.00K	-$582.0K
YoY Change	308.11%	-29.73%	-133.11%
Pretax Income	$1.754M	$3.505M	-$5.422M
YoY Change	51.73%	-46.1%	-146.65%
Income Tax	$158.0K	$173.0K	-$64.00K
% Of Pretax Income	9.01%	4.94%
Net Earnings	$1.370M	$3.195M	-$5.928M
YoY Change	79.79%	-39.2%	-163.87%
Net Earnings / Revenue	2.89%	6.26%	-3.21%
Basic Earnings Per Share	$0.38	$0.89	-$1.65
Diluted Earnings Per Share	$0.38	$0.88	-$1.65
COMMON SHARES
Basic Shares Outstanding	3.604M shares	3.601M shares	3.601M shares
Diluted Shares Outstanding	3.631M shares	3.641M shares	3.601M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.12M	$13.99M	$13.42M
YoY Change	-57.41%	-47.43%	-52.86%
Cash & Equivalents	$12.12M	$13.99M	$13.42M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$1.368M	$1.762M	$1.781M
YoY Change	-58.56%	-47.68%	-46.05%
Inventory	$2.972M	$3.249M	$3.093M
Prepaid Expenses
Receivables	$4.632M	$3.748M	$3.313M
Other Receivables	$306.0K	$336.0K	$328.0K
Total Short-Term Assets	$21.40M	$23.08M	$21.93M
YoY Change	-45.26%	-40.83%	-43.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.52M	$34.63M	$130.8M
YoY Change	-3.34%	-0.47%	-4.13%
Goodwill	$7.440M	$17.44M
YoY Change	-57.34%	0.0%
Intangibles	$4.220M	$4.220M
YoY Change	0.0%	0.0%
Long-Term Investments	$6.518M	$6.496M	$6.507M
YoY Change	0.82%	0.64%	0.65%
Other Assets	$2.161M	$2.154M	$5.899M
YoY Change	-14.38%	-15.66%	4.56%
Total Long-Term Assets	$152.2M	$163.9M	$155.0M
YoY Change	-10.73%	14.02%	-9.04%
TOTAL ASSETS
Total Short-Term Assets	$21.40M	$23.08M	$21.93M
Total Long-Term Assets	$152.2M	$163.9M	$155.0M
Total Assets	$173.6M	$187.0M	$177.0M
YoY Change	-17.17%	2.31%	-15.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.573M	$4.383M	$4.058M
YoY Change	2.4%	-18.73%	-9.14%
Accrued Expenses	$16.48M	$16.22M	$15.86M
YoY Change	-10.0%	-3.21%	-13.4%
Deferred Revenue	$3.418M	$4.579M
YoY Change	-38.24%	-2.26%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.011M	$1.983M	$1.987M
YoY Change	-69.41%	-70.36%	-69.78%
Total Short-Term Liabilities	$26.48M	$27.16M	$27.86M
YoY Change	-24.09%	-18.97%	-20.13%
LONG-TERM LIABILITIES
Long-Term Debt	$4.649M	$5.630M	$5.140M
YoY Change	-72.8%	-69.06%	-69.92%
Other Long-Term Liabilities	$90.14M	$91.25M	$92.23M
YoY Change	-7.49%	27.51%	-5.35%
Total Long-Term Liabilities	$94.79M	$96.88M	$97.37M
YoY Change	-17.24%	7.93%	-14.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.48M	$27.16M	$27.86M
Total Long-Term Liabilities	$94.79M	$96.88M	$97.37M
Total Liabilities	$121.3M	$124.0M	$126.7M
YoY Change	-18.84%	0.61%	-15.4%
SHAREHOLDERS EQUITY
Retained Earnings	$36.79M	$47.13M
YoY Change	-16.91%	7.22%
Common Stock	$14.97M	$14.12M
YoY Change	-3.63%	-8.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$51.75M	$61.25M	$50.29M
YoY Change
Total Liabilities & Shareholders Equity	$173.6M	$187.0M	$177.0M
YoY Change	-17.17%	2.31%	-15.55%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	$1.370M	$3.195M	-$5.928M
YoY Change	79.79%	-39.2%	-163.87%
Depreciation, Depletion And Amortization	$1.092M	$1.059M	$4.225M
YoY Change	3.8%	4.03%	0.76%
Cash From Operating Activities	$558.0K	$4.761M	$8.386M
YoY Change	-87.63%	-56.21%	-58.79%
INVESTING ACTIVITIES
Capital Expenditures	$276.0K	$1.032M	$3.857M
YoY Change	-130.13%	-261.5%	42.8%
Acquisitions
YoY Change
Other Investing Activities	$22.00K	$42.00K	$5.133M
YoY Change	-100.43%	-193.33%	-201.44%
Cash From Investing Activities	-$254.0K	-$990.0K	$1.276M
YoY Change	-95.76%	44.74%	-116.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00		$531.0K
YoY Change	-100.0%		-66.2%
Cash From Financing Activities	-$1.597M	-7.675M	-$19.69M
YoY Change	-5.33%	260.5%	136.67%
NET CHANGE
Cash From Operating Activities	$558.0K	4.761M	$8.386M
Cash From Investing Activities	-$254.0K	-990.0K	$1.276M
Cash From Financing Activities	-$1.597M	-7.675M	-$19.69M
Net Change In Cash	-$1.293M	-3.904M	-$10.02M
YoY Change	-59.12%	-148.44%	-334.86%
FREE CASH FLOW
Cash From Operating Activities	$558.0K	$4.761M	$8.386M
Capital Expenditures	$276.0K	$1.032M	$3.857M
Free Cash Flow	$282.0K	$3.729M	$4.529M
YoY Change	-94.8%	-67.61%	-74.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Auditor Name AuditorName	CohnReznick LLP
CY2023	dei	Auditor Firm AuditorFirmId	596
CY2023	dei	Auditor Location AuditorLocation	Melville, New York
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13415000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23439000	usd
CY2023Q3	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	0	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	5021000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3313000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3185000	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	328000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	440000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	3093000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3707000	usd
CY2023Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	212000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1778000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1569000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1523000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	21930000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	39093000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34314000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34682000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	96459000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	101720000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7440000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	17440000	usd
CY2023Q3	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	4220000	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	4220000	usd
CY2023Q3	arkr	Intangible Assets Net IntangibleAssetsNet	187000	usd
CY2022Q4	arkr	Intangible Assets Net IntangibleAssetsNet	272000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3738000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3118000	usd
CY2023Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	6507000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	6465000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2161000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2524000	usd
CY2023Q3	us-gaap	Assets Assets	176956000	usd
CY2022Q4	us-gaap	Assets Assets	209534000	usd
CY2023Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4058000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4466000	usd
CY2023Q3	arkr	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	13829000	usd
CY2022Q4	arkr	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	16312000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7988000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7530000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1987000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	6575000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27862000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	34883000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92232000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	97444000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	5140000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	17089000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	125234000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	149416000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3604000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3604000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3600000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3600000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14161000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	15493000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	36091000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	44271000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	50288000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	59800000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	1434000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	318000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51722000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60118000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176956000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	209534000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184793000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	183674000	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	60000000	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	23498000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12407000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12936000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10000000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4310000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	189633000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	173810000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4840000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	9864000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1239000	usd
CY2022	us-gaap	Interest Expense InterestExpense	1192000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	333000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	109000	usd
CY2023	us-gaap	Other Income OtherIncome	52000	usd
CY2022	us-gaap	Other Income OtherIncome	421000	usd
CY2023	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	272000	usd
CY2022	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	2420000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-582000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1758000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5422000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11622000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-64000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1448000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-5358000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	10174000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	570000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	893000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5928000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9281000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.65
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.61
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.65
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.58
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3601000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3556000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3601000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3603000	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51452000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	703000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	298000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1615000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.25
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	894000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60118000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-5358000	usd
CY2023	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	0	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	314000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1139000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.625
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	2252000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51722000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-5358000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	10174000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	314000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	298000	usd
CY2023	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	272000	usd
CY2022	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	2420000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-620000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	582000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10000000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4310000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4297000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	507000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	873000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	63000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	48000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	128000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-928000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-614000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	197000	usd
CY2023	arkr	Increase Decrease In Prepaid And Accrued Income Taxes IncreaseDecreaseInPrepaidAndAccruedIncomeTaxes	-1566000	usd
CY2022	arkr	Increase Decrease In Prepaid And Accrued Income Taxes IncreaseDecreaseInPrepaidAndAccruedIncomeTaxes	-2118000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1682000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-363000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	254000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-408000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-420000	usd
CY2023	arkr	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	-2477000	usd
CY2022	arkr	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	2699000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8386000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20347000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3857000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2701000	usd
CY2023	arkr	Loans And Advances Made To Employees LoansAndAdvancesMadeToEmployees	71000	usd
CY2022	arkr	Loans And Advances Made To Employees LoansAndAdvancesMadeToEmployees	229000	usd
CY2023	arkr	Payments Received On Employee Receivables PaymentsReceivedOnEmployeeReceivables	183000	usd
CY2022	arkr	Payments Received On Employee Receivables PaymentsReceivedOnEmployeeReceivables	169000	usd
CY2023	arkr	Payments To Acquire Certificates Of Deposit PaymentsToAcquireCertificatesOfDeposit	0	usd
CY2022	arkr	Payments To Acquire Certificates Of Deposit PaymentsToAcquireCertificatesOfDeposit	5000000	usd
CY2023	arkr	Proceeds From Maturity Of Certificate Of Deposit ProceedsFromMaturityOfCertificateOfDeposit	5021000	usd
CY2022	arkr	Proceeds From Maturity Of Certificate Of Deposit ProceedsFromMaturityOfCertificateOfDeposit	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1276000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7761000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15803000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4941000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	531000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1571000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2252000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	894000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	39000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	703000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1139000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1615000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19686000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8318000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10024000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4268000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23439000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19171000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13415000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23439000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1291000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1119000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	345000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	826000	usd
CY2023	arkr	Noncash Decrease In Noncontrolling Interest From Deconsolidation NoncashDecreaseInNoncontrollingInterestFromDeconsolidation	1685000	usd
CY2022	arkr	Noncash Decrease In Noncontrolling Interest From Deconsolidation NoncashDecreaseInNoncontrollingInterestFromDeconsolidation	0	usd
CY2023	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The Company's fiscal year ends on the Saturday nearest September 30. The fiscal years ended September 30, 2023 and October 1, 2022 both included 52 weeks.</span></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are used for, but are not limited to: (i) projected cash flows related to asset impairments, including goodwill and intangibles, (ii) income tax valuation allowances for deferred tax assets, (iii) allowances for potential bad debts on receivables, (iv) assumptions regarding discount rates related to lease accounting, (v) the useful lives and recoverability of our long-lived assets, such as fixed assets and intangibles, (vi) fair values of financial instruments, (vii) share-based compensation, (viii) estimates made in connection with acquisition purchase price allocations, (ix) uncertain tax positions, and (x) determining when investment impairments are other-than-temporary. The Company’s accounting estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The accounting estimates may change as new events occur, as more experience is acquired and as more information is obtained. The Company evaluates and updates assumptions and estimates on an ongoing basis and may use outside experts to assist in the Company’s evaluation, as considered necessary. Actual results could differ from those estimates.
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	101853000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company reduces credit risk by placing its cash and cash equivalents with major financial institutions with high credit ratings. At times, such amounts may exceed federally insured limits. Accounts receivable are primarily comprised of normal business receivables, such as credit card receivables, that are collected in a short period of time and amounts due from the hotel operators where the Company has a location, and are recorded upon satisfaction of the performance obligation. The Company reviews the collectability of its receivables on an ongoing basis, and has not provided for an allowance as it considers all of the counterparties will be able to meet their obligations. The concentration of credit risk with respect to accounts receivable is generally limited due to the short payment terms extended by the Company and the number of customers comprising the Company’s customer base.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, the Company had accounts receivable balances due from one hotel operator totaling 52% of total accounts receivable. As of October 1, 2022, the Company had accounts receivable balances due from two hotel operators totaling 54% of total accounts receivable.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended September 30, 2023 and October 1, 2022, the Company made purchases from two vendors that accounted for 22% and 20% of total purchases, respectively.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, all debt outstanding, other than the note payable to the sellers of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Blue Moon Fish Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, is with one lender (see Note 10 – Notes Payable).</span></div>
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	97996000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67539000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10000000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63314000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34314000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34682000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4225000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4193000	usd
CY2023Q3	arkr	Liability For Gift Cards Included In Accrued Expenses And Other Current Liabilities LiabilityForGiftCardsIncludedInAccruedExpensesAndOtherCurrentLiabilities	340000	usd
CY2022Q4	arkr	Liability For Gift Cards Included In Accrued Expenses And Other Current Liabilities LiabilityForGiftCardsIncludedInAccruedExpensesAndOtherCurrentLiabilities	309000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10000000	usd
CY2023Q3	arkr	Goodwill Impairment Loss Tax Deductible GoodwillImpairmentLossTaxDeductible	8000000	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2300000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	17440000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q3	arkr	Number Of Vi Es With Primary Benefits NumberOfVIEsWithPrimaryBenefits	3	entity
CY2023Q3	arkr	Number Of Vi Es With Primary Benefits NumberOfVIEsWithPrimaryBenefits	3	entity
CY2023Q3	arkr	Operating Lease Payments Decrease OperatingLeasePaymentsDecrease	0.19
CY2023Q3	arkr	Lessee Operating Lease Notice To Vacate LesseeOperatingLeaseNoticeToVacate	P12M
CY2023Q3	arkr	Land And Building Gross LandAndBuildingGross	18393000	usd
CY2022Q4	arkr	Land And Building Gross LandAndBuildingGross	18033000	usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	44308000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	43054000	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	39025000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	36554000	usd
CY2023Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	127000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	355000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	17440000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7440000	usd
CY2023Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	10000000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2023Q3	arkr	Intangible Assets Gross Excluding Trade Marks And Goodwill IntangibleAssetsGrossExcludingTradeMarksAndGoodwill	2628000	usd
CY2022Q4	arkr	Intangible Assets Gross Excluding Trade Marks And Goodwill IntangibleAssetsGrossExcludingTradeMarksAndGoodwill	2628000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2441000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2356000	usd
CY2023Q3	arkr	Intangible Assets Net IntangibleAssetsNet	187000	usd
CY2022Q4	arkr	Intangible Assets Net IntangibleAssetsNet	272000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	85000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	104000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	85000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	85000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	17000	usd
CY2023Q3	arkr	Sales Tax Payable Current SalesTaxPayableCurrent	765000	usd
CY2022Q4	arkr	Sales Tax Payable Current SalesTaxPayableCurrent	916000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4487000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5517000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5962000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5534000	usd
CY2023Q3	arkr	Accrued Occupancy And Other Operating Expenses Current AccruedOccupancyAndOtherOperatingExpensesCurrent	2615000	usd
CY2022Q4	arkr	Accrued Occupancy And Other Operating Expenses Current AccruedOccupancyAndOtherOperatingExpensesCurrent	4345000	usd
CY2023Q3	arkr	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	13829000	usd
CY2022Q4	arkr	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	16312000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	13672000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	10442000	usd
CY2023	arkr	Occupancy Lease Cost OccupancyLeaseCost	334000	usd
CY2022	arkr	Occupancy Lease Cost OccupancyLeaseCost	461000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	4184000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	6498000	usd
CY2023	us-gaap	Lease Cost LeaseCost	18190000	usd
CY2022	us-gaap	Lease Cost LeaseCost	17401000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	18669000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	14633000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3860000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53530000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y10M24D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0625
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13941000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	12881000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	12143000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11960000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12057000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	79284000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	142266000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42046000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	100220000	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	7222000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	23729000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1987000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	6575000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-95000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-65000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	5140000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	17089000	usd
CY2022	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	2420000	usd
CY2023	arkr	Paycheck Protection Program Loan Interest Forgiveness Income PaycheckProtectionProgramLoanInterestForgivenessIncome	6000	usd
CY2022	arkr	Paycheck Protection Program Loan Interest Forgiveness Income PaycheckProtectionProgramLoanInterestForgivenessIncome	65000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	304000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	63000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	48000	usd
CY2023Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	542000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2023Q3	arkr	Lessee Operating Lease Number Of Renewal Terms LesseeOperatingLeaseNumberOfRenewalTerms	1	option
CY2023Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2018Q2	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	2	plaintiff
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	63750	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	500000	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.032
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.497
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.042
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	544125	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.63
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	22500	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.80
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3750	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.65
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48851	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.40
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	69125	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	20.50
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	26000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	18.27
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	471250	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.57
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	413000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	544125	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.63
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	840000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	310125	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.21
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	207000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	302125	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.98
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	477500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	477500	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	314000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	298000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	228000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y6M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	471250	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.57
CY2023	arkr	Sharebased Compensation Arrangement By Sharebased Payment Award Option Outstanding And Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingAndExercisableWeightedAverageRemainingContractualTerm	P5Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	310125	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	20.21
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2023	arkr	Maximum Amount Of Compensation Paid Under Cash Bonus Plan MaximumAmountOfCompensationPaidUnderCashBonusPlan	1000000	usd
CY2023	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	272000	usd
CY2022	arkr	Paycheck Protection Program Loan Forgiveness Income PaycheckProtectionProgramLoanForgivenessIncome	2420000	usd
CY2023	arkr	Paycheck Protection Program Loan Interest Forgiveness Income PaycheckProtectionProgramLoanInterestForgivenessIncome	6000	usd
CY2022	arkr	Paycheck Protection Program Loan Interest Forgiveness Income PaycheckProtectionProgramLoanInterestForgivenessIncome	65000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	319000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	817000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	237000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	49000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	556000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	866000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-237000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	173000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-383000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	409000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-620000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	582000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-64000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1448000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1139000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2440000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-241000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	275000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	419000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2023	arkr	Effective Income Tax Rate Reconciliation Paycheck Protection Program Income Loss Amount EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramIncomeLossAmount	57000	usd
CY2022	arkr	Effective Income Tax Rate Reconciliation Paycheck Protection Program Income Loss Amount EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramIncomeLossAmount	432000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	961000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	998000	usd
CY2023	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	120000	usd
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	188000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	49000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	22000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1866000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	149000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	120000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	180000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-64000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1448000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5170000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5293000	usd
CY2023Q3	arkr	Deferred Tax Asset Lease Liabilities DeferredTaxAssetLeaseLiabilities	22072000	usd
CY2022Q4	arkr	Deferred Tax Asset Lease Liabilities DeferredTaxAssetLeaseLiabilities	22570000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	376000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	336000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2483000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2269000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	511000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	604000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	30612000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31072000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27339000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	29665000	usd
CY2023Q3	arkr	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	23065000	usd
CY2022Q4	arkr	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	25886000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	188000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	271000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	348000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	390000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	23601000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	26547000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3738000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3118000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3273000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1407000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1803000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	149000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	159000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	120000	usd
CY2023	arkr	Unrecognized Tax Benefits Increases Resulting From Current And Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentAndPriorPeriodTaxPositions	26000	usd
CY2022	arkr	Unrecognized Tax Benefits Increases Resulting From Current And Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentAndPriorPeriodTaxPositions	39000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	185000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	159000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3601000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3556000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	47000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3601000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3603000	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	471250	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	329125	shares
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.1875
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.1875

Files In Submission

Name	View Source	Status
arkr-20230930_cal.xml	Edgar Link	unprocessable
0000779544-23-000044-index-headers.html	Edgar Link	pending
0000779544-23-000044-index.html	Edgar Link	pending
0000779544-23-000044.txt	Edgar Link	pending
0000779544-23-000044-xbrl.zip	Edgar Link	pending
a32023exhibit21.htm	Edgar Link	pending
a42023exhibit23.htm	Edgar Link	pending
a52023exhibit311.htm	Edgar Link	pending
a62023exhibit312.htm	Edgar Link	pending
a72023exhibit32.htm	Edgar Link	pending
arkr-20230930.htm	Edgar Link	pending
arkr-20230930.xsd	Edgar Link	pending
arkr-20230930_g1.jpg	Edgar Link	pending
arkrestaurantscorp-incenti.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
arkr-20230930_def.xml	Edgar Link	unprocessable
arkr-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
arkr-20230930_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
arkr-20230930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARKR
ARK RESTAURANTS CORP Stock $arkr

2023 Q4 Form 10-K Financial Statement

#000077954423000044 Filed on December 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARKR ARK RESTAURANTS CORP Stock $arkr

2023 Q4 Form 10-K Financial Statement

#000077954423000044 Filed on December 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARKR
ARK RESTAURANTS CORP Stock $arkr